C G de Waal1,2, L Uijterschout1,3, M Abbink4, B Boersma4, P Vos5, W W Rövekamp1, F Hudig6, M D Akkermans1, J B van Goudoever2,7, F Brus1. 1. Department of Pediatrics, Juliana Children's Hospital, HAGA Teaching Hospital, The Hague, The Netherlands. 2. Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands. 3. Department of Pediatrics, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. 4. Department of Pediatrics, Medical Center Alkmaar, Alkmaar, The Netherlands. 5. Department of Pediatrics, Medical Center Haaglanden, The Hague, The Netherlands. 6. Department of Clinical Chemistry, LabWest, HAGA Teaching Hospital, The Hague, the Netherlands. 7. Department of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands.
Abstract
OBJECTIVE: To determine the natural course of zinc protoporphyrin/heme ratio (ZnPP/H) and its role in the detection of iron deficiency (ID) and iron-deficiency anemia (IDA) in the first 4 months of life in moderately preterm infants. STUDY DESIGN: ZnPP/H was measured at 1 week, 6 weeks and 4 months postnatal age in a prospective cohort of 161 Dutch infants born at a gestational age of 32+0 to 36+6 weeks who did not receive an erythrocyte transfusion or iron supplementation. RESULTS: ZnPP/H levels decreased in the first 6 weeks and increased thereafter. At 4 months postnatal age, ZnPP/H was higher in the 11 (8.5%) infants with IDA (mean (s.d.): 260.8 (16.1)) but not in the 27 (21.3%) infants with ID (mean (s.d.): 177.0 (15.1)) compared with normal infants (mean (s.d.): 157.3 (12.5)). CONCLUSION: In moderately preterm infants, ZnPP/H can be of additional value to detect infants at risk for IDA due to iron-deficient erythropoiesis at 4 months of age.
OBJECTIVE: To determine the natural course of zinc protoporphyrin/heme ratio (ZnPP/H) and its role in the detection of iron deficiency (ID) and iron-deficiency anemia (IDA) in the first 4 months of life in moderately preterm infants. STUDY DESIGN:ZnPP/H was measured at 1 week, 6 weeks and 4 months postnatal age in a prospective cohort of 161 Dutch infants born at a gestational age of 32+0 to 36+6 weeks who did not receive an erythrocyte transfusion or iron supplementation. RESULTS:ZnPP/H levels decreased in the first 6 weeks and increased thereafter. At 4 months postnatal age, ZnPP/H was higher in the 11 (8.5%) infants with IDA (mean (s.d.): 260.8 (16.1)) but not in the 27 (21.3%) infants with ID (mean (s.d.): 177.0 (15.1)) compared with normal infants (mean (s.d.): 157.3 (12.5)). CONCLUSION: In moderately preterm infants, ZnPP/H can be of additional value to detect infants at risk for IDA due to iron-deficient erythropoiesis at 4 months of age.
Authors: Georgia Metzgeroth; Verena Adelberger; Alexandra Dorn-Beineke; Christian Kuhn; Michael Schatz; Ole Maywald; Thomas Bertsch; Hermann Wisser; Rüdiger Hehlmann; Jan Hastka Journal: Eur J Haematol Date: 2005-10 Impact factor: 2.997
Authors: Yvonne Schönbeck; Henk Talma; Paula van Dommelen; Boudewijn Bakker; Simone E Buitendijk; Remy A HiraSing; Stef van Buuren Journal: Pediatr Res Date: 2012-12-10 Impact factor: 3.756
Authors: Ashajyothi M Siddappa; Raghavendra Rao; Jeffrey D Long; John A Widness; Michael K Georgieff Journal: Neonatology Date: 2007-03-14 Impact factor: 4.035
Authors: Lieke Uijterschout; Magnus Domellöf; Staffan K Berglund; Micky Abbink; Paul Vos; Lyanne Rövekamp; Bart Boersma; Carina Lagerqvist; Cisca Hudig; Johannes B van Goudoever; Frank Brus Journal: Pediatr Res Date: 2015-12-16 Impact factor: 3.756